These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 26348443)

  • 1. Comparing computer-generated and pathologist-generated tumour segmentations for immunohistochemical scoring of breast tissue microarrays.
    Akbar S; Jordan LB; Purdie CA; Thompson AM; McKenna SJ
    Br J Cancer; 2015 Sep; 113(7):1075-80. PubMed ID: 26348443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AutoIHC-Analyzer: computer-assisted microscopy for automated membrane extraction/scoring in HER2 molecular markers.
    Tewary S; Arun I; Ahmed R; Chatterjee S; Mukhopadhyay S
    J Microsc; 2021 Jan; 281(1):87-96. PubMed ID: 32803890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated tumor identification and automated scoring minimizes pathologist involvement and provides new insights to key biomarkers in breast cancer.
    Bankhead P; Fernández JA; McArt DG; Boyle DP; Li G; Loughrey MB; Irwin GW; Harkin DP; James JA; McQuaid S; Salto-Tellez M; Hamilton PW
    Lab Invest; 2018 Jan; 98(1):15-26. PubMed ID: 29251737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study on breast carcinoma Her2/neu and hormonal receptors status assessed by automated images analysis systems: ACIS III (Dako) and ScanScope (Aperio).
    Słodkowska J; Filas V; Buszkiewicz E; Trzeciak P; Wojciechowski M; Koktysz R; Staniszewski W; Breborowicz J; Rojo MG
    Folia Histochem Cytobiol; 2010 Jan; 48(1):19-25. PubMed ID: 20529811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fast unsupervised nuclear segmentation and classification scheme for automatic allred cancer scoring in immunohistochemical breast tissue images.
    Mouelhi A; Rmili H; Ali JB; Sayadi M; Doghri R; Mrad K
    Comput Methods Programs Biomed; 2018 Oct; 165():37-51. PubMed ID: 30337080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRF-ANN: a machine learning approach for automated ER scoring of breast cancer immunohistochemical images.
    Mungle T; Tewary S; Das DK; Arun I; Basak B; Agarwal S; Ahmed R; Chatterjee S; Chakraborty C
    J Microsc; 2017 Aug; 267(2):117-129. PubMed ID: 28319275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of automated image analysis of breast cancer tissue microarrays for epidemiologic studies.
    Bolton KL; Garcia-Closas M; Pfeiffer RM; Duggan MA; Howat WJ; Hewitt SM; Yang XR; Cornelison R; Anzick SL; Meltzer P; Davis S; Lenz P; Figueroa JD; Pharoah PD; Sherman ME
    Cancer Epidemiol Biomarkers Prev; 2010 Apr; 19(4):992-9. PubMed ID: 20332278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative comparison of immunohistochemical staining measured by digital image analysis versus pathologist visual scoring.
    Rizzardi AE; Johnson AT; Vogel RI; Pambuccian SE; Henriksen J; Skubitz AP; Metzger GJ; Schmechel SC
    Diagn Pathol; 2012 Jun; 7():42. PubMed ID: 22515559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automated quantitative analysis of estrogen receptor expression in breast carcinoma does not differ from expert pathologist scoring: a tissue microarray study of 3,484 cases.
    Turbin DA; Leung S; Cheang MC; Kennecke HA; Montgomery KD; McKinney S; Treaba DO; Boyd N; Goldstein LC; Badve S; Gown AM; van de Rijn M; Nielsen TO; Gilks CB; Huntsman DG
    Breast Cancer Res Treat; 2008 Aug; 110(3):417-26. PubMed ID: 17912629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Astronomical algorithms for automated analysis of tissue protein expression in breast cancer.
    Ali HR; Irwin M; Morris L; Dawson SJ; Blows FM; Provenzano E; Mahler-Araujo B; Pharoah PD; Walton NA; Brenton JD; Caldas C
    Br J Cancer; 2013 Feb; 108(3):602-12. PubMed ID: 23329232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AutoIHC-scoring: a machine learning framework for automated Allred scoring of molecular expression in ER- and PR-stained breast cancer tissue.
    Tewary S; Arun I; Ahmed R; Chatterjee S; Chakraborty C
    J Microsc; 2017 Nov; 268(2):172-185. PubMed ID: 28613390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virtual tissue microarrays: a novel and viable approach to optimizing tissue microarrays for biomarker research applied to ductal carcinoma in situ.
    Quintayo MA; Starczynski J; Yan FJ; Wedad H; Nofech-Mozes S; Rakovitch E; Bartlett JM
    Histopathology; 2014 Jul; 65(1):2-8. PubMed ID: 24267587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous measurement of breast tumour hormone receptor expression: a comparison of two computational pathology platforms.
    Ahern TP; Beck AH; Rosner BA; Glass B; Frieling G; Collins LC; Tamimi RM
    J Clin Pathol; 2017 May; 70(5):428-434. PubMed ID: 27729430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interobserver agreement for estrogen receptor immunohistochemical analysis in breast cancer: a comparison of manual and computer-assisted scoring methods.
    Diaz LK; Sahin A; Sneige N
    Ann Diagn Pathol; 2004 Feb; 8(1):23-7. PubMed ID: 15129906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automated image analysis for high-throughput quantitative detection of ER and PR expression levels in large-scale clinical studies: the TEAM Trial Experience.
    Faratian D; Kay C; Robson T; Campbell FM; Grant M; Rea D; Bartlett JM
    Histopathology; 2009 Nov; 55(5):587-93. PubMed ID: 19912364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue microarrays compared with whole sections and biochemical analyses. A subgroup analysis of DBCG 82 b&c.
    Kyndi M; Sørensen FB; Knudsen H; Overgaard M; Nielsen HM; Andersen J; Overgaard J
    Acta Oncol; 2008; 47(4):591-9. PubMed ID: 18465327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer.
    Sinn HP; Schneeweiss A; Keller M; Schlombs K; Laible M; Seitz J; Lakis S; Veltrup E; Altevogt P; Eidt S; Wirtz RM; Marmé F
    BMC Cancer; 2017 Feb; 17(1):124. PubMed ID: 28193205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptor antibody incubation time and extent of immunoreactivity in invasive carcinoma of the breast: the importance of optimizing antibody avidity.
    Goldstein NS; Hunter S; Forbes S; Odish E; Tehrani M
    Appl Immunohistochem Mol Morphol; 2007 Jun; 15(2):203-7. PubMed ID: 17525635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous automatic scoring and co-registration of hormone receptors in tumor areas in whole slide images of breast cancer tissue slides.
    Trahearn N; Tsang YW; Cree IA; Snead D; Epstein D; Rajpoot N
    Cytometry A; 2017 Jun; 91(6):585-594. PubMed ID: 28009468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new automatic image analysis method for assessing estrogen receptors' status in breast tissue specimens.
    Mouelhi A; Sayadi M; Fnaiech F; Mrad K; Ben Romdhane K
    Comput Biol Med; 2013 Dec; 43(12):2263-77. PubMed ID: 24290943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.